Cargando…
Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma
Renal cell carcinoma (RCC) is a common urological tumor, with a poor prognosis, as the result of insensitivity to chemotherapy and radiotherapy. About 20%–30% of patients with RCC have metastasis at the first diagnosis, so only systemic treatment is possible. Due to the heterogeneity of renal tumors...
Autores principales: | Wang, Bingran, Xue, Yizheng, Zhai, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111175/ https://www.ncbi.nlm.nih.gov/pubmed/35592336 http://dx.doi.org/10.3389/fimmu.2022.902060 |
Ejemplares similares
-
Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma
por: Xue, Yizheng, et al.
Publicado: (2022) -
Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
por: Tran, Florian, et al.
Publicado: (2020) -
Organoid Models for Precision Cancer Immunotherapy
por: Sun, Cai-Ping, et al.
Publicado: (2022) -
Cancer organoid co-culture model system: Novel approach to guide precision medicine
por: Yuan, Jin, et al.
Publicado: (2023) -
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma
por: Fu, Liangmin, et al.
Publicado: (2022)